Digital transformation in pharma has accelerated faster than perhaps once anticipated, as a result of the COVID-19 pandemic. It’s a topic that is causing debate and ...

Antibiotics, antidepressants and other drugs frequently leach into the environment, where they can impact ecosystems and human health. Many of the world’s waterwa...

Threshold Pharma is to go ahead with Phase 3 clinical trials of its only drug, TH-302, despite recent Phase 2 trials failing to show statistically significant improv...

Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), today announced that it has completed its first life cycle assessment (LC...

Along with PCI’s own robust infrastructure expansions, acquisition furthers CDMO’s recent growth in sterile fill-finish, advanced drug delivery systems lik...

What happens when over 300 pharmaceutical leaders from across Europe and beyond gather in Berlin? Insightful discussions, strategic collaboration and opinions exchan...

GSK reaffirmed its 2025 outlook and said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, after reporting stronger-than-expected first-quart...

European Commission grants authorisation for Eisai and Biogen therapy The European Commission has granted marketing authorisation for Leqembi (lecanemab), making ...

Aspen’s share price plummeted by 30% after it warned shareholders that its earnings could significantly decline due to a material contractual dispute. Aspen, base...

Japanese pharma group Eisai says it is battling a ransomware attack that was launched last weekend and has resulted in some of its servers becoming encrypted. The...